/
/
/

Innova Captab Results

Financial overview

CAGR%
Sales
Profits
Returns
ROE
10Y5Y3YTTM
-32%21%31%
-33%28%10%
---24%
24%22%15%14%

Peer Comparison

Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
LAURUSLABS
ZYDUSLIFE
DRREDDY
CIPLA
MANKIND
AUROPHARMA
LUPIN
INNOVACAP
PriceM.Cap (₹)PE RatioEPS (₹)EV/EBITDAAnnual PAT
1,783.4₹425150 Cr38.778.2958.23₹11479 Cr
10,003.5₹266265 Cr91.0334.04128.41₹2568 Cr
4,690₹176301 Cr8314.04106.21₹2163 Cr
2,306.3₹125352 Cr93.568.1733.94₹889 Cr
1,206.1₹123591 Cr27.399.4262.53₹5040 Cr
1,367₹114351 Cr40.8411.0859.2₹4196 Cr
1,395.5₹112474 Cr38.8210.8652.6₹3879 Cr
2,513.8₹102315 Cr45.6217.2376.26₹1913 Cr
1,707.5₹97757 Cr26.3317.9596.84₹3505 Cr
2,021.7₹92007 Cr16.6430.95154.35₹5333 Cr
1,041.1₹5741 Cr36.737.7135.32₹141 Cr

Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
₹471 Cr₹448 Cr₹450 Cr₹380 Cr₹352 Cr₹315 Cr₹316 Cr₹318 Cr₹294 Cr₹263 Cr₹302 Cr₹283 Cr₹233 Cr₹241 Cr₹242 Cr₹242 Cr
₹2 Cr₹2 Cr₹2 Cr₹4 Cr₹4 Cr₹3 Cr₹4 Cr₹2 Cr₹2 Cr₹6 Cr₹2 Cr₹3 Cr₹1 Cr₹3 Cr₹3 Cr₹2 Cr
₹473 Cr₹449 Cr₹452 Cr₹385 Cr₹356 Cr₹318 Cr₹321 Cr₹320 Cr₹296 Cr₹268 Cr₹305 Cr₹286 Cr₹234 Cr₹244 Cr₹245 Cr₹244 Cr
₹409 Cr₹394 Cr₹392 Cr₹340 Cr₹310 Cr₹277 Cr₹275 Cr₹273 Cr₹257 Cr₹228 Cr₹263 Cr₹247 Cr₹205 Cr₹217 Cr₹211 Cr₹214 Cr
₹75 Cr₹67 Cr₹71 Cr₹56 Cr₹57 Cr₹51 Cr₹51 Cr₹52 Cr₹44 Cr₹44 Cr₹47 Cr₹44 Cr₹32 Cr₹29 Cr₹37 Cr₹33 Cr
₹4 Cr₹5 Cr₹4 Cr₹5 Cr₹3 Cr₹2 Cr₹17 L₹15 L₹14 L₹81 L₹7 Cr₹9 Cr₹5 Cr₹5 Cr₹6 Cr₹5 Cr
₹59 Cr₹51 Cr₹56 Cr₹39 Cr₹43 Cr₹39 Cr₹46 Cr₹47 Cr₹39 Cr₹40 Cr₹35 Cr₹30 Cr₹25 Cr₹21 Cr₹28 Cr₹25 Cr
₹44 Cr₹40 Cr₹42 Cr₹30 Cr₹31 Cr₹29 Cr₹34 Cr₹35 Cr₹29 Cr₹29 Cr₹25 Cr₹23 Cr₹18 Cr₹17 Cr₹20 Cr₹19 Cr

Balance Sheet

Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Other Long Term Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Capital Work in Progress
Long Term Loans & Advances
Other Non Current Assets
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
————————
₹57 Cr₹57 Cr₹57 Cr₹48 Cr₹12 Cr₹12 Cr₹12 Cr₹12 Cr
₹1034 Cr₹902 Cr₹774 Cr₹229 Cr₹197 Cr₹133 Cr₹98 Cr₹70 Cr
₹1034 Cr₹902 Cr₹774 Cr₹229 Cr₹197 Cr₹133 Cr₹98 Cr₹70 Cr
₹1091 Cr₹959 Cr₹831 Cr₹277 Cr₹209 Cr₹145 Cr₹110 Cr₹82 Cr
₹215 Cr₹244 Cr₹208 Cr₹62 Cr₹40 Cr₹6 Cr₹12 Cr₹26 Cr
₹0₹0₹0₹72 Cr₹27 Cr₹0₹0₹0
₹23 Cr₹95 L-₹15 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹1 Cr
₹1 Cr₹1 Cr₹2 Cr₹9 Cr₹68 L₹48 L₹64 L₹21 L
₹12 Cr₹10 Cr₹9 Cr₹47 Cr₹18 Cr₹36 Cr₹56 L₹42 L
₹251 Cr₹256 Cr₹205 Cr₹194 Cr₹88 Cr₹44 Cr₹14 Cr₹28 Cr
————————
₹319 Cr₹202 Cr₹180 Cr₹158 Cr₹145 Cr₹112 Cr₹72 Cr₹62 Cr
₹69 Cr₹77 Cr₹58 Cr₹21 Cr₹28 Cr₹69 Cr₹12 Cr₹10 Cr
₹99 Cr₹66 Cr₹24 Cr₹98 Cr₹120 Cr₹33 Cr₹36 Cr₹40 Cr
₹30 Cr₹32 Cr₹32 Cr₹58 L₹22 Cr₹53 L₹10 Cr₹6 Cr
₹517 Cr₹376 Cr₹294 Cr₹278 Cr₹315 Cr₹215 Cr₹129 Cr₹117 Cr
₹1858 Cr₹1592 Cr₹1329 Cr₹748 Cr₹612 Cr₹404 Cr₹254 Cr₹228 Cr
₹0₹0₹0₹6 L₹7 L₹6 L₹1 Cr₹1 Cr
₹343 Cr₹336 Cr₹242 Cr₹235 Cr₹198 Cr₹45 Cr₹54 Cr₹72 Cr
————————
₹956 Cr₹901 Cr₹406 Cr₹216 Cr₹206 Cr₹107 Cr₹94 Cr₹90 Cr
₹114 Cr₹71 Cr₹49 Cr₹33 Cr₹23 Cr₹28 Cr₹21 Cr₹11 Cr
₹842 Cr₹830 Cr₹358 Cr₹183 Cr₹183 Cr₹79 Cr₹73 Cr₹78 Cr
₹16 Cr₹23 Cr₹341 Cr₹22 Cr₹3 L₹7 Cr₹0₹0
₹16 Cr₹7 Cr₹22 Cr₹101 Cr₹29 Cr₹48 Cr₹85 L₹1 Cr
₹40 Cr₹6 Cr₹50 L₹26 L₹28 L₹0₹0₹0
₹913 Cr₹865 Cr₹721 Cr₹306 Cr₹212 Cr₹134 Cr₹74 Cr₹80 Cr
————————
₹41 Cr₹0₹0₹0₹0₹0₹0₹0
₹283 Cr₹208 Cr₹144 Cr₹117 Cr₹128 Cr₹91 Cr₹65 Cr₹39 Cr
₹437 Cr₹332 Cr₹288 Cr₹265 Cr₹213 Cr₹139 Cr₹87 Cr₹91 Cr
₹4 Cr₹68 Cr₹87 Cr₹19 Cr₹2 Cr₹12 Cr₹5 Cr₹2 Cr
₹65 Cr₹33 Cr₹9 Cr₹13 Cr₹6 Cr₹3 Cr₹1 Cr₹1 Cr
₹114 Cr₹78 Cr₹80 Cr₹28 Cr₹50 Cr₹26 Cr₹22 Cr₹16 Cr
₹945 Cr₹719 Cr₹608 Cr₹442 Cr₹400 Cr₹270 Cr₹180 Cr₹148 Cr
₹428 Cr₹343 Cr₹314 Cr₹165 Cr₹85 Cr₹55 Cr₹51 Cr₹31 Cr
₹1858 Cr₹1592 Cr₹1329 Cr₹748 Cr₹612 Cr₹404 Cr₹254 Cr₹228 Cr
₹191₹168₹145₹58₹1,738₹1,207₹920₹687
₹191₹168₹145₹58₹43₹30₹23₹17

Cash Flow

Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Cash & Cash Equivalent on Amalgamation / Take over / Merger
Closing Cash & Cash Equivalent
Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2019
₹188 Cr₹171 Cr₹130 Cr₹92 Cr₹86 Cr₹46 Cr₹38 Cr₹25 Cr
₹58 Cr₹27 Cr₹37 Cr₹26 Cr₹15 Cr₹10 Cr₹14 Cr₹16 Cr
-₹103 Cr-₹111 Cr₹7 Cr-₹31 Cr-₹21 Cr-₹1 Cr-₹12 Cr-₹13 Cr
₹143 Cr₹88 Cr₹174 Cr₹87 Cr₹80 Cr₹55 Cr₹40 Cr₹28 Cr
₹117 Cr₹64 Cr₹146 Cr₹67 Cr₹59 Cr₹42 Cr₹31 Cr₹19 Cr
-₹107 Cr-₹152 Cr-₹499 Cr-₹91 Cr-₹188 Cr-₹20 Cr-₹6 Cr-₹9 Cr
-₹22 Cr₹92 Cr₹361 Cr₹27 Cr₹125 Cr-₹19 Cr-₹23 Cr-₹9 Cr
-₹12 Cr₹4 Cr₹8 Cr₹3 Cr-₹5 Cr₹3 Cr₹1 Cr₹54 L
₹16 Cr₹12 Cr₹4 Cr₹15 L₹5 Cr₹2 Cr₹75 L₹21 L
₹0₹0₹0₹0₹0₹50,000₹0₹0
₹3 Cr₹16 Cr₹12 Cr₹4 Cr₹15 L₹5 Cr₹2 Cr₹75 L

Fundamental Ratios

Consolidated
Standalone
Empty box

No results found

Share Price Live Stats

Open (₹)989.30
Volume (₹)47,946.00
High (₹)1,050.70
Upper Circuit1,203.90
Low (₹)962.20
Lower Circuit802.70
Prev Close1,003.30
52W High (₹)1,353.50
Price1,041.10
52W Low (₹)622.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)5740.80 Cr
Div. Yield (%)0.20
PE Ratio36.73
Debt to Equity0.31
Price to Book3.61
Book Value190.62
EPS (TTM)27.31
Face Value10.00
ROE (%)13.75

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
LAURUSLABSNSE
ZYDUSLIFENSE
DRREDDYNSE
CIPLANSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
INNOVACAPNSE
LTP
1W Low
1W High
Market cap (₹)
1783.4+5.7 (0.32%)
1722
1810.40
4,25,150Cr
10003.5+223.5 (2.29%)
9863
10067
2,66,265Cr
4690+76.6 (1.66%)
4553
4703.10
1,76,301Cr
2306.3-99.2 (-4.12%)
2252.40
2441.90
1,25,352Cr
1206.1-39.4 (-3.16%)
1182.40
1266.60
1,23,591Cr
1367+15 (1.11%)
1336.70
1376.70
1,14,351Cr
1395.5+16.6 (1.20%)
1364.60
1400.80
1,12,474Cr
2513.8+21 (0.84%)
2457.90
2515
1,02,315Cr
1707.5+26.1 (1.55%)
1656.20
1724.60
97,757Cr
2021.7+10.7 (0.53%)
1988.90
2062.10
92,007Cr
1041.1+15.8 (1.54%)
962.20
1050.70
5,741Cr

Innova Captab Ltd Annual Results Key Takeaways

Operating profit (before other income, interest and exceptional items) was ₹75.13Cr; with other income of ₹2.01Cr, profit before interest and tax came to ₹63.41Cr. Interest expense was ₹4.43Cr; PBT before exceptional items stood at ₹58.98Cr. Cost mix (full year): raw materials ₹838.16Cr; employee cost ₹167.2Cr; depreciation ₹11.71Cr; other expenses ₹397.73Cr. Basis: consolidated annual results.

Innova Captab Ltd Quaterly Results Key Takeaways

Innova Captab Ltd reported ₹470.85Cr total income from operations in Jun 2026, softer than ₹447.8Cr in Mar 2026 but higher than ₹351.54Cr in Jun 2025. Operating profit (before other income, interest and exceptional items) was ₹75.13Cr; with other income of ₹2.01Cr, profit before interest and tax came to ₹63.41Cr. Interest expense was ₹4.43Cr, taking profit before tax to ₹58.98Cr. After tax of ₹14.86Cr, profit after tax stood at ₹44.13Cr (vs ₹40.35Cr in Mar 2026 and ₹31.02Cr in Jun 2025).